These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20844427)

  • 1. HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture.
    Ofotokun I; Weitzmann MN
    Curr Opin Endocrinol Diabetes Obes; 2010 Dec; 17(6):523-9. PubMed ID: 20844427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
    McGinty T; Mallon P
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and bone disease.
    Compston J
    J Intern Med; 2016 Oct; 280(4):350-8. PubMed ID: 27272530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.
    Anuurad E; Semrad A; Berglund L
    Metab Syndr Relat Disord; 2009 Oct; 7(5):401-10. PubMed ID: 19355810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do people with HIV infection have a higher risk of fracture compared with those without HIV infection?
    Hoy J; Young B
    Curr Opin HIV AIDS; 2016 May; 11(3):301-5. PubMed ID: 26882459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Loss Among Women Living With HIV.
    Weitzmann MN; Ofotokun I; Titanji K; Sharma A; Yin MT
    Curr HIV/AIDS Rep; 2016 Dec; 13(6):367-373. PubMed ID: 27678124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.
    Rothman MS; Bessesen MT
    Curr Osteoporos Rep; 2012 Dec; 10(4):270-7. PubMed ID: 23100110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging with HIV: osteoporosis and fractures.
    Mallon PW
    Curr Opin HIV AIDS; 2014 Jul; 9(4):428-35. PubMed ID: 24871090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and bone loss.
    Arora S; Agrawal M; Sun L; Duffoo F; Zaidi M; Iqbal J
    Curr Osteoporos Rep; 2010 Dec; 8(4):219-26. PubMed ID: 20830538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
    Madeddu G; Spanu A; Solinas P; Calia GM; Lovigu C; Chessa F; Mannazzu M; Falchi A; Mura MS; Madeddu G
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of HIV Infection and Antiretroviral Therapy on Bone Homeostasis.
    Delpino MV; Quarleri J
    Front Endocrinol (Lausanne); 2020; 11():502. PubMed ID: 32982960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone disease in the setting of HIV infection: update and review of the literature.
    Castronuovo D; Cacopardo B; Pinzone MR; Di Rosa M; Martellotta F; Schioppa O; Moreno S; Nunnari G
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2413-9. PubMed ID: 24089217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging, human immunodeficiency virus, and bone health.
    Mansky KC
    Clin Interv Aging; 2010 Sep; 5():285-92. PubMed ID: 20924437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.
    Wyatt CM; Klotman PE
    Expert Opin Drug Saf; 2006 Mar; 5(2):275-87. PubMed ID: 16503748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of HIV to bone mineral density].
    Wessman M; Weis N; Katzenstein TL; Lebech AM; Thorsteinsson K; Hansen AE; Jensen JB
    Ugeskr Laeger; 2017 Sep; 179(36):. PubMed ID: 28874254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.
    Pan G; Yang Z; Ballinger SW; McDonald JM
    Ann N Y Acad Sci; 2006 Apr; 1068():297-308. PubMed ID: 16831930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multifactorial relations between HIV, HAART and bone metabolism].
    Borderi M
    Infez Med; 2006 Sep; 14(3):117-24. PubMed ID: 17127825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study.
    Hansen AB; Gerstoft J; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Obel N
    AIDS; 2012 Jan; 26(3):285-93. PubMed ID: 22095195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.